Skip to main content

pSP150
(Plasmid #247111)

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 247111 Standard format: Plasmid sent in bacteria as agar stab 1 $94

Backbone

  • Vector backbone
    pUC57
  • Vector type
    Bacterial Expression, Affinity Reagent/ Antibody ; Maintenance in bacteria

Growth in Bacteria

  • Bacterial Resistance(s)
    Kanamycin, 50 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    DH5alpha
  • Copy number
    High Copy

Gene/Insert 1

  • Gene/Insert name
    GFP Nanobody
  • Species
    Camellid
  • Insert Size (bp)
    354

Cloning Information for Gene/Insert 1

Gene/Insert 2

  • Gene/Insert name
    Rat Rnf4
  • Species
    R. norvegicus (rat)
  • Insert Size (bp)
    360
  • Entrez Gene
    Rnf4

Cloning Information for Gene/Insert 2

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry

Trademarks:

  • Zeocin® is an InvivoGen trademark.

Depositor Comments

The gpdA-driven reverse tet transactivator protein and tet-on-minimal promoter were obtained from Dr. Fabio Gsaller and the construction of these two features is described here: https://pubmed.ncbi.nlm.nih.gov/36350143/ .The 4X HA-GFPNb-rnf4 fusion gene was synthesized with A. fumigatus codon bias by Genscript. The GFP nanobody sequence-Rnf4 fusion was taken directly from: https://pmc.ncbi.nlm.nih.gov/articles/PMC7332993/ .

How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pSP150 was a gift from Scott Moye-Rowley (Addgene plasmid # 247111 ; http://n2t.net/addgene:247111 ; RRID:Addgene_247111)
  • For your References section:

    Regulated proteolysis of green fluorescent protein fusion proteins in Aspergillus fumigatus. Paul S, Moye-Rowley WS. G3 (Bethesda). 2026 Feb 4;16(2):jkaf295. doi: 10.1093/g3journal/jkaf295. 10.1093/g3journal/jkaf295 PubMed 41351542